# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-075911
Filing Date
2025-04-09
Accepted
2025-04-08 17:35:17
Documents
15
Period of Report
2025-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d907211d8k.htm iXBRL | 8-K | 61105
2 | EX-4.1 | d907211dex41.htm | EX-4.1 | 1012453
3 | EX-10.1 | d907211dex101.htm | EX-10.1 | 1484456
| Complete submission text file | 0001193125-25-075911.txt |  | 3287534

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | bhc-20250408.xsd | EX-101.SCH | 2519
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bhc-20250408_lab.xml | EX-101.LAB | 17911
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bhc-20250408_pre.xml | EX-101.PRE | 11229
18 | EXTRACTED XBRL INSTANCE DOCUMENT | d907211d8k_htm.xml | XML | 3751

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 25823100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)